The epidemiology, pathogenesis and histopathology of fatty liver disease
- PMID: 22372457
- DOI: 10.1111/j.1365-2559.2011.04145.x
The epidemiology, pathogenesis and histopathology of fatty liver disease
Abstract
Fatty liver disease includes non-alcoholic fatty liver disease (NAFLD) and alcoholic liver disease (ALD), each of which is increasing in prevalence. Each represents a histological spectrum that extends from isolated steatosis to steatohepatitis and cirrhosis. NAFLD is associated with obesity, diabetes, and insulin resistance, and is considered to be the liver manifestation of the metabolic syndrome. The pathogenesis of NAFLD and ALD involves cytokines, adipokines, oxidative stress, and apoptosis. Histopathology is the gold standard for assessing the severity of liver damage in NAFLD and ALD. We have reviewed the literature, and described and compared the epidemiology, natural disease history, pathogenesis and histopathology of NAFLD and ALD.
© 2012 Blackwell Publishing Ltd.
Similar articles
-
What are the risk factors and settings for non-alcoholic fatty liver disease in Asia-Pacific?J Gastroenterol Hepatol. 2007 Jun;22(6):794-800. doi: 10.1111/j.1440-1746.2007.04952.x. Epub 2007 May 13. J Gastroenterol Hepatol. 2007. PMID: 17498218
-
Insulin resistance and oxidative stress interdependency in non-alcoholic fatty liver disease.Trends Mol Med. 2006 Dec;12(12):555-8. doi: 10.1016/j.molmed.2006.10.001. Epub 2006 Oct 17. Trends Mol Med. 2006. PMID: 17049925
-
Review article: current management of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis.Aliment Pharmacol Ther. 2008 Jul;28(1):2-12. doi: 10.1111/j.1365-2036.2008.03710.x. Epub 2008 Apr 11. Aliment Pharmacol Ther. 2008. PMID: 18410557 Review.
-
ASH and NASH.Dig Dis. 2011;29(2):202-10. doi: 10.1159/000323886. Epub 2011 Jul 5. Dig Dis. 2011. PMID: 21734385 Review.
-
Non-alcoholic fatty liver disease: further expression of the metabolic syndrome.J Gastroenterol Hepatol. 2007 Mar;22(3):293-303. doi: 10.1111/j.1440-1746.2007.04824.x. J Gastroenterol Hepatol. 2007. PMID: 17295757 Review.
Cited by
-
Deletion of Perilipin 5 Protects Against Hepatic Injury in Nonalcoholic Fatty Liver Disease via Missing Inflammasome Activation.Cells. 2020 May 28;9(6):1346. doi: 10.3390/cells9061346. Cells. 2020. PMID: 32481590 Free PMC article.
-
Herbal SGR Formula Prevents Acute Ethanol-Induced Liver Steatosis via Inhibition of Lipogenesis and Enhancement Fatty Acid Oxidation in Mice.Evid Based Complement Alternat Med. 2015;2015:613584. doi: 10.1155/2015/613584. Epub 2015 May 25. Evid Based Complement Alternat Med. 2015. PMID: 26101535 Free PMC article.
-
Defining hepatic dysfunction parameters in two models of fatty liver disease in zebrafish larvae.Zebrafish. 2013 Jun;10(2):199-210. doi: 10.1089/zeb.2012.0821. Epub 2013 May 22. Zebrafish. 2013. PMID: 23697887 Free PMC article.
-
Mechanistic study of attenuation of monosodium glutamate mixed high lipid diet induced systemic damage in rats by Coccinia grandis.Sci Rep. 2020 Sep 22;10(1):15443. doi: 10.1038/s41598-020-72076-6. Sci Rep. 2020. PMID: 32963259 Free PMC article.
-
Distinctive gut microbial dysbiosis between chronic alcoholic fatty liver disease and metabolic-associated fatty liver disease in mice.Exp Ther Med. 2021 May;21(5):418. doi: 10.3892/etm.2021.9862. Epub 2021 Feb 25. Exp Ther Med. 2021. PMID: 33777186 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources